How Frequently Do You Reassess Your Patients with ADHD if They Are:
AAFP, N (%) | ACHA, N (%) | Total, N (%) | |
---|---|---|---|
Children (0 to 13 y.o.). | |||
Monthly | 72 (11.4) | 5 (4.6) | 77 (10.4) |
Every 2 to 3 months | 207 (32.9) | 6 (5.5) | 213 (28.8) |
Every 3 to 6 months | 164 (26.0) | 2 (1.8) | 166 (22.5) |
Every 6 to 9 months | 29 (4.6) | 1 (0.9) | 30 (4.1) |
Never | 5 (0.8) | 1 (0.9) | 6 (0.8) |
Not applicable | 153 (24.3) | 94 (86.2) | 247 (33.4) |
Total | 630 | 109 | 739 |
Teenagers (13 to 18 y.o.). | |||
Monthly | 74 (11.8) | 19 (17.1) | 93 (12.6) |
Every 2 to 3 months | 201 (32.0) | 12 (10.8) | 213 (28.8) |
Every 3 to 6 months | 191 (30.4) | 6 (5.4) | 197 (26.7) |
Every 6 to 9 months | 42 (6.7) | 1 (0.9) | 43 (5.8) |
Never | 2 (0.3) | 1 (0.9) | 3 (0.4) |
Not applicable | 118 (18.8) | 72 (64.9) | 190 (25.7) |
Total | 628 | 111 | 739 |
Young adult (17 to 26 y.o.). | |||
Monthly | 58 (9.2) | 35 (30.2) | 93 (12.5) |
Every 2 to 3 months | 205 (32.5) | 20 (17.2) | 225 (30.2) |
Every 3 to 6 months | 208 (33.0) | 15 (12.9) | 223 (29.9) |
Every 6 to 9 months | 66 (10.5) | 4 (3.4) | 70 (9.4) |
Never | 2 (0.3) | 1 (0.9) | 3 (0.4) |
Not applicable | 91 (14.4) | 41 (35.3) | 132 (17.7) |
Total | 630 | 116 | 746 |
Adult (26 and older y.o.). | |||
Monthly | 47 (7.5) | 15 (13.4) | 62 (8.4) |
Every 2 to 3 months | 173 (27.5) | 22 (19.6) | 195 (26.4) |
Every 3 to 6 months | 215 (34.2) | 18 (16.1) | 233 (31.5) |
Every 6 to 9 months | 96 (15.3) | 4 (3.6) | 100 (13.5) |
Never | 3 (0.5) | 2 (1.8) | 5 (0.7) |
Not applicable | 94 (15.0) | 51 (45.5) | 145 (19.6) |
Total | 628 | 112 | 740 |
On ADHD stimulant medication. | |||
Monthly | 67 (10.7) | 34 (30.4) | 101 (13.6) |
Every 2 to 3 months | 202 (32.1) | 20 (17.9) | 222 (30.0) |
Every 3 to 6 months | 212 (33.7) | 13 (11.6) | 225 (30.4) |
Every 6 to 9 months | 61 (9.7) | 3 (2.7) | 64 (8.6) |
Never | 2 (0.3) | 1 (0.9) | 3 (0.4) |
Not applicable | 85 (13.5) | 41 (36.6) | 126 (17.0) |
Total | 629 | 112 | 741 |
Just initiating treatment. | |||
Monthly | 424 (67.5) | 58 (52.3) | 482 (65.2) |
Every 2 to 3 months | 81 (12.9) | 3 (2.7) | 84 (11.4) |
Every 3 to 6 months | 21 (3.3) | 0 (0.0) | 21 (2.8) |
Every 6 to 9 months | 5 (0.8) | 2 (1.8) | 7 (0.9) |
Never | 2 (0.3) | 1 (0.9) | 3 (0.4) |
Not applicable | 95 (15.1) | 47 (42.3) | 142 (19.2) |
Total | 628 | 111 | 739 |
In their first 2 years of treatment. | |||
Monthly | 54 (8.6) | 23 (20.7) | 77 (10.5) |
Every 2 to 3 months | 235 (37.6) | 28 (25.2) | 263 (35.7) |
Every 3 to 6 months | 215 (34.4) | 14 (12.6) | 229 (31.1) |
Every 6 to 9 months | 35 (5.6) | 4 (3.6) | 39 (5.3) |
Never | 2 (0.3) | 2 (1.8) | 4 (0.5) |
Not applicable | 84 (13.4) | 40 (36.0) | 124 (16.8) |
Total | 625 | 111 | 736 |
Stable on treatment after 2 years. | |||
Monthly | 18 (2.9) | 14 (12.6) | 32 (4.4) |
Every 2 to 3 months | 150 (24.1) | 20 (18.0) | 170 (23.2) |
Every 3 to 6 months | 227 (36.4) | 23 (20.7) | 250 (34.1) |
Every 6 to 9 months | 141 (22.6) | 13 (11.7) | 154 (21.0) |
Never | 3 (0.5) | 1 (0.9) | 4 (0.5) |
Not applicable | 84 (13.5) | 40 (36.0) | 124 (16.9) |
Total | 623 | 111 | 734 |